Related Experiment Video

Updated: Jul 16, 2026

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
02:47

Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System

Published on: May 12, 2023

New vectors and strategies for cardiovascular gene therapy

Agnieszka Jazwa1, Alicja Jozkowicz, Jozef Dulak

  • 1Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.

Current Gene Therapy
|February 20, 2007
PubMed

Insights

Gene therapy offers a promising alternative for cardiovascular diseases caused by impaired blood vessel formation. Recent advancements focus on novel gene delivery vectors, like adeno-associated virus (AAV) serotypes, and combined therapeutic strategies for enhanced angiogenesis.

Area of Science:

  • Cardiovascular Medicine
  • Gene Therapy
  • Molecular Biology

Background:

  • Cardiovascular diseases are a leading cause of death in developed nations.
  • Impaired angiogenesis, especially in response to hypoxia, contributes to cardiovascular disorders.
  • Gene therapy presents a potential alternative for patients unsuitable for conventional revascularization.

Purpose of the Study:

  • To review recent advancements in gene delivery vectors for cardiovascular applications.
  • To highlight novel gene therapy strategies for treating ischemic cardiovascular diseases.
  • To discuss the potential of adeno-associated virus (AAV) serotypes in gene therapy.

Main Methods:

  • Review of current literature on gene therapy for cardiovascular diseases.
  • Focus on development of novel gene delivery vectors, including AAV serotypes.
  • Analysis of emerging cardiovascular gene therapy strategies.

Main Results:

  • New AAV serotypes and modified forms show promise as gene delivery vectors.
  • Combination therapies involving multiple angiogenic growth factors are being explored.
  • Simultaneous application of genes and progenitor cells aims to restore vascular function in ischemic tissues.

Conclusions:

  • Gene therapy, particularly using advanced AAV vectors, is an evolving field for cardiovascular disease treatment.
  • Innovative strategies like combined gene therapy and cell therapy hold potential for stable blood vessel regeneration.
  • Further research into gene delivery and therapeutic strategies is crucial for clinical translation.

More Related Videos

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart06:07

Large Animal Model for Evaluating the Efficacy of the Gene Therapy in Ischemic Heart

Published on: September 2, 2021

Gene Transfer for Ischemic Heart Failure in a Preclinical Model07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...